Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than a buck. -- Ignore unavailable to you. Want to Upgrade?

To: RWReeves who wrote (591)	7/25/2000 11:39:33 AM
From: Mike McFarland	Read Replies (1) \| Respond to of 743

VPHM did nicely for the bottomfishers, but it has given some back, falling from nearly $22 to $18 in just the past few days. It might be worth nibbling again. After a false start in GNLB, I started a small position just under $4, but the early SI thread really poo poos the prospects for the Lupis drug, and seems not a lot better than placebo--I bought a few shares on a longer term speculation for their antiviral. Urban crows and West Nile--only a matter of time GNLB spikes on some sort of media attention perhaps? Very small position, more DD required. I like cash here too, BTK looks just awful, so I have the wife at more than half cash. I'm averaging around 15% cash, but would like to be around a third, and a whole mess of mental stops will put me there in short order. March/April conditioned me for this, what can you do--twice shy.